Homology Medicines
BEDFORD, MA · Founded 2015 · CIK 0001661998 · Biotech · Acquired
proprietary AAV gene editing platform for rare genetic diseases using human hematopoietic stem cells
homologymedicines.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $107M
- 2 Form D · Aug 2017
- 110 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 40
- 8 granted · 32 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2015201620172018
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $23,068,876 | |
| Private capital raised | Form D · SEC | $83,500,008 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2014 | SixPeaks Bio | — | — |
| 2015 | OSTREA BIO, INC. | — | — |
| 2016 | Crystalys | — | — |
| 2017 | Homology Medicines | — | $107M |
| 2018 | Braveheart Bio | — | — |
| 2019 | Outer Biosciences, LLC | — | $4.0M |
| 2020 | VITAKEY, INC. | — | $44M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Steven GillisDirector
- Richard GregoryDirector
- Kush ParmarDirector · Executive Officer
- Siyamak RastyExecutive Officer
- Albert SeymourExecutive Officer
- Mahendra ShahDirector
- Brad SmithExecutive Officer
- Paul StoneDirector · Executive Officer
- Arthur TzianabosDirector · Executive Officer
- Cameron WheelerDirector
Patents
- Adeno-associated Virus Compositions And Methods Of Use Thereofapplication
- Adeno-associated Virus Compositions For Restoring Pah Gene Function And Methods Of Use Thereofgranted
- Adeno-associated Virus Compositions For Restoring Pah Gene Function And Methods Of Use Thereofgranted
- Adeno-associated Virus Compositions For Pah Gene Transfer And Methods Of Use Thereofgranted
- Adeno-associated Virus Compositions For Pah Gene Transfer And Methods Of Use Thereofgranted
- Methods Of Treating Phenylketonuriagranted
- Adeno-associated Virus Compositions For Restoring F8 Gene Function And Methods Of Use Thereofgranted
- Liver De-targeted Recombinant Aav Capsid Proteinsapplication
- Bidirectional Dual Promoter Expression Vectors And Uses Thereofapplication
- Methods And Compositions For The Production Of Adeno-associated Virusapplication
- Methods And Compositions For The Purification Of Adeno-associated Virusapplication
- Non-naturally Occurring Polyadenylation Elements And Methods Of Use Thereofapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.